Lia DeGroot – Endpoints News

about the author

Lia DeGroot

ldegroot@endpointsnews.com

author articles

Why the Supreme Court's overrule of Chevron has major implications for the FDA

11 months ago

House panel advances bill to allow Medicare to cover obesity drugs

11 months ago

Haleon to sell nicotine replacement therapy business to Dr. Reddy’s for $630M

11 months ago

Q&A: FDA medical policy chief talks decentralized trial guidance, improving diversity

11 months ago

CBER chief floats rare disease hub to better communicate across centers

11 months ago

International society criticizes Utah law for permitting unapproved stem cell therapies

11 months ago

Amgen nabs new Blincyto approval for certain type of leukemia

11 months ago

FDA asks Covid-19 vaccine makers to instead target KP.2 strain for fall season

11 months ago

Stakeholders weigh in on potential reforms to FDA advisory committee process

11 months ago

Lilly, Eisai and Biogen seek more specifics in FDA guidance on early Alzheimer’s disease

11 months ago

Updated: FDA funding would stay flat under House appropriations bill

11 months ago

Sanders pushes subpoena vote to force testimony of Novo Nordisk exec on GLP-1 prices

11 months ago

FDA establishes new meeting type to advise on drug safety technology

11 months ago

GSK wins expanded FDA approval for RSV shot in at-risk adults ages 50 to 59

11 months ago

FDA greenlights Geron’s imetelstat to treat anemia in certain cancer patients

11 months ago

Senate fails to pass bill codifying access to contraception

11 months ago

Senate Finance Chair presses HHS to crack down on cybersecurity in wake of UnitedHealth attack

11 months ago

House lawmakers float transparency reforms for 340B program at hearing

11 months ago

Fauci pushes back on pandemic criticisms before divided House panel

11 months ago

Novartis sues Maryland over state law banning limits on discounts to 340B contract pharmacies

11 months ago

Lab group sues FDA over final rule regulating laboratory-developed tests

12 months ago

Doctors who endorse drugs on social media are often compensated, JAMA study finds

12 months ago

FDA approves Tris Pharma's non-stimulant pediatric ADHD liquid medication

12 months ago

Amgen nabs FDA approval for first Soliris interchangeable biosimilar

12 months ago

12 3 4 Next page Last page